Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 46
- Uncategorized
Maximizing Profits by Minimizing Cultivation Risks Through Expert Support
Cannabis cultivation is a complex endeavour that goes beyond conventional horticulture.
- Uncategorized
What’s on the Horizon for Cannabis in 2025?
The North American cannabis industry in 2024 experienced a pivotal year of progress and challenges, setting the stage for a transformative 2025.
- Opinion
What’s in Store for the European Cannabis Industry in 2025? (Part 2)
Written by Ben Stevens and Sarah Sinclair. You can read Part 1 here.
- Opinion
What’s in Store for the European Cannabis Industry in 2025? (Part 1)
Written by Ben Stevens and Sarah Sinclair. 2024 has been a dramatic year for the global cannabis industry, seeing both historic steps forward and concerning regressions in both attitudes and policy.
- Press releases
Launch of Exports by Tikun Olam Europe
In a landmark moment for the Greek medical cannabis industry, Tikun Olam Europe, the 1st Medical Cannabis Company in Greece, sets new standards and achieves another first by completing the 1st export of finished medical cannabis products from Greece
- Hemp Industry
Hemp Industry Leaders of Texas Demand Law Enforcement Stop Using Questionable Standards
Over the past year, local police and sheriff’s departments have relied on faulty testing of legal hemp products. These departments are using analytical methods that the Texas Department of Public Safety official testified to in front of a legislative committee – that the analytical methods should be used to determine the legality of products sold in Texas.
- Uncategorized
US Farm Bill Delayed for 3rd Time, Leaving ‘Intoxicating Hemp’ Regulation in Limbo
The highly anticipated US Farm Bill has been pushed back until next year, leaving the future regulation of intoxicating hemp substances in the hands of individual states.
- Markets & Stocks
BAT Announces 2nd £200m Fund With More Cannabis Investment Expected, Jazz Pharma Looks for New CEO, & Synbiotic Partners With Canna-Tech Firm
British American Tobacco [stock_market_widget type=”chart” template=”line” assets=”BATS.L” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Tobacco giant British American Tobacco (BAT) has announced the launch of a second investment fund as part of its corporate venture arm, Btomorrow Ventures (BTV).
- Medical
French Medical Cannabis Patients Warned That Treatment Will be ‘No Longer Accessible From January’ Amid Political Chaos
French patient associations have warned that medical cannabis patients could soon face a disruption in treatment as its long-running experiment comes to an end with no next steps in place.
- Hemp Industry
Could Hemp-Based Construction Unlock Labour’s Housing Ambitions?
Last week, UK Prime Minister Keir Starmer committed to building 1.5 million homes over the current parliament, targeting the construction of 300,000 homes annually to align with long-advocated figures to address under-supply.
- Uncategorized
Canada Announces Plans to Reform Cannabis Excise Tax in 2025
Canada is set to explore a new excise tax system for cannabis businesses next year in welcome and long-awaited efforts to ‘cut red tape’.
- Uncategorized
New York’s Cannabis Businesses Face Further Delays as Lawsuit Halts License Processing Again
New York’s troubled adult-use cannabis program has hit yet another legal roadblock after a state judge barred regulators from processing business applications.












